Published: 2021-02-19

Glycogen synthase kinase-3: a new therapeutic target in mood disorders

Feyza Aricioglu, Salih Gumru

(193-198)

DOI: https://doi.org/ 10.5455/bcp.20130624022007

Glycogen synthase kinase-3: a new therapeutic target in mood disorders

Feyza Aricioglu, Salih Gumru

(193-198)

DOI: https://doi.org/ 10.5455/bcp.20130624022007

Relationships between use of long acting antipsychotics and sociodemographic and clinical characteristics of patients with schizophrenia

Yakup Albayrak, Cuneyt Unsal, Murat Beyazyuz

(171-179)

DOI: https://doi.org/10.5455/bcp.20130408021412

The effect of methylphenidate on executive functions in children with Attention-Deficit Hyperactivity Disorder

Alper Yilmaz, Cem Gokcen, Emine Cigil Fettahoglu, Esin Ozatalay

(162-170)

DOI: https://doi.org/10.5455/bcp.20121130090251

Descriptive features of depressive disorder patients with who have committed suicide by drug overdose

Muhammed Nabi Kantarci, Eyup Kandemir, Mustafa Balkay, Gurol Berber, Omer Faruk Demirel, Murat Emul, Hamdi Tutkun

(155-161)

DOI: https://doi.org/10.5455/bcp.20120412022107

Risk management in tianeptine abuse in Turkey: a national experience

Nedim Durmus, Gamze Ozbilen, Yelda Kasap, Oguzhan Koyuncu, Osman Yildirim, Guven Artiran, Saim Kerman, Demet Aydinkarahaliloglu

(149-154)

DOI: https://doi.org/10.5455/bcp.20130426010958

Personality traits of schizophrenic patients in remission and their first-degree relatives: a dopaminergic and glutamatergic gene polymorphism study

Vesile Altinyazar, Azad Gunderici

(138-148)

DOI: https://doi.org/10.5455/bcp.20130308015536

Relationships between use of long acting antipsychotics and sociodemographic and clinical characteristics of patients with schizophrenia

Yakup Albayrak, Cuneyt Unsal, Murat Beyazyuz

(171-179)

DOI: https://doi.org/10.5455/bcp.20130408021412

The effect of methylphenidate on executive functions in children with Attention-Deficit Hyperactivity Disorder

Alper Yilmaz, Cem Gokcen, Emine Cigil Fettahoglu, Esin Ozatalay

(162-170)

DOI: https://doi.org/10.5455/bcp.20121130090251

Descriptive features of depressive disorder patients with who have committed suicide by drug overdose

Muhammed Nabi Kantarci, Eyup Kandemir, Mustafa Balkay, Gurol Berber, Omer Faruk Demirel, Murat Emul, Hamdi Tutkun

(155-161)

DOI: https://doi.org/10.5455/bcp.20120412022107

Risk management in tianeptine abuse in Turkey: a national experience

Nedim Durmus, Gamze Ozbilen, Yelda Kasap, Oguzhan Koyuncu, Osman Yildirim, Guven Artiran, Saim Kerman, Demet Aydinkarahaliloglu

(149-154)

DOI: https://doi.org/10.5455/bcp.20130426010958

Personality traits of schizophrenic patients in remission and their first-degree relatives: a dopaminergic and glutamatergic gene polymorphism study

Vesile Altinyazar, Azad Gunderici

(138-148)

DOI: https://doi.org/10.5455/bcp.20130308015536

Metoclopramide induced akathisia: a case report

Aslihan Okan Ibiloglu

(186-189)

DOI: https://doi.org/10.5455/bcp.20120419121147

Fluoxetine induced hypomanic shift in a bulimic patient: case report

Mustafa Ozten, Atila Erol

(183-185)

DOI: https://doi.org/10.5455/bcp.20130112010027

Idiopathic thrombocytopenia side-effect of lithium in a patient with schizophrenia

Branislav O Šakić, Josip Dj Dadasović

(180-182)

DOI: https://doi.org/10.5455/bcp.20130301022331

Metoclopramide induced akathisia: a case report

Aslihan Okan Ibiloglu

(186-189)

DOI: https://doi.org/10.5455/bcp.20120419121147

Fluoxetine induced hypomanic shift in a bulimic patient: case report

Mustafa Ozten, Atila Erol

(183-185)

DOI: https://doi.org/10.5455/bcp.20130112010027

Idiopathic thrombocytopenia side-effect of lithium in a patient with schizophrenia

Branislav O Šakić, Josip Dj Dadasović

(180-182)

DOI: https://doi.org/10.5455/bcp.20130301022331

Vitamin E Treatment for Olanzapine Induced Tardive Dyskinesia in an Adolescent with Bipolar Disorder

Ali Evren Tufan, Irem Yalug, Rabia Bilici

(190-192)

DOI: https://doi.org/ 10.5455/bcp.20121130085643

Vitamin E Treatment for Olanzapine Induced Tardive Dyskinesia in an Adolescent with Bipolar Disorder

Ali Evren Tufan, Irem Yalug, Rabia Bilici

(190-192)

DOI: https://doi.org/ 10.5455/bcp.20121130085643

Novel Targets for Development of Drugs for Treating Schizophrenia: Focus on Glycine, D-Serine and Nitric Oxide

Kamaldeep Dhami, Marnie MacKay, Joao Paulo Maia-de- Oliveira, Jaime Hallak, Kathryn Todd, Glen Baker, Serdar Dursun

(129-137)

DOI: https://doi.org/ 10.5455/bcp.20130629042437

Novel Targets for Development of Drugs for Treating Schizophrenia: Focus on Glycine, D-Serine and Nitric Oxide

Kamaldeep Dhami, Marnie MacKay, Joao Paulo Maia-de- Oliveira, Jaime Hallak, Kathryn Todd, Glen Baker, Serdar Dursun

(129-137)

DOI: https://doi.org/ 10.5455/bcp.20130629042437